LAROXYL 50 mg/2 ml, solution for injection 12 ampoules of 2 ml
Active ingredients: Amitriptyline, Amitriptyline hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection12 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAROXYL 50 mg/2 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 12 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1964
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68330257CIP73057294CIP133400930572948Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMITRIPTYLINEsolution | — | SA |
| AMITRIPTYLINEsolution | 50 mg · une ampoule de 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.